Please assess the completion status of the following clinical trial:

Trial Title: A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* adult patients, 18-64 years of age;~* ambulatory;~* influenza-like illness;~* positive rapid assay for detection of influenza antigen.~Exclusion Criteria:~* presentation \>36h after onset of symptoms;~* influenza-like symptoms outside an outbreak based on local surveillance activities;~* influenza vaccination between November 2006 and January 2007;~* receipt of antiviral therapy, systemic steroids or immunosuppressants within 2 weeks prior to study day 1.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).